AABB is urging hospitals to remain highly vigilant in managing their blood inventories, especially type O negative red blood cells and AB plasma, as these products are in short supply this summer. AABB recommends hospitals reserve AB plasma for blood group AB patients with definitive transfusion needs. For situations where type O negative red blood cells and AB plasma are used as part of a massive transfusion protocol for patients of unknown blood type, every effort should be made to obtain a blood type for the patient as soon as possible. “Maintaining a safe and adequate blood supply is critical to the nation’s public health and a priority for the medical community,” said Miriam A. Markowitz, CEO of AABB. Hospitals are urged to follow available clinical practice guidelines for the appropriate use of individual blood products. AHA and AABB collaborated on a toolkit to assist hospitals as they implement a patient blood management approach as a component of their care planning decisions. 

Related News Articles

Headline
The White House Dec. 11 issued an executive order to establish a national artificial intelligence framework to preempt state regulation. The order calls for…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Cybersecurity and Infrastructure Security Agency Dec. 11 released an update to its voluntary Cybersecurity Performance Goals, which includes measurable…
Headline
The AHA Dec. 11 expressed support for the reintroduction of the Future Advancement of Academic Nursing, bicameral legislation that would increase nursing…
Headline
The Centers for Medicare & Medicaid Services Dec. 11 announced the launch of the Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based…
Perspective
Public
Every day the women and men of America’s hospitals and health systems work together to deliver lifesaving care to patients and communities. Nurses monitor…